Hydrogen sulfide attenuates opioid dependence by suppression of adenylate cyclase/cAMP pathway

Antioxidants and Redox Signaling

Volumn 20, Issue 1, 2014, Pages 31-41

  Yang, Hai Yu ^a,b   Wu, Zhi Yuan ^a   Wood, Mark ^c   Whiteman, Matthew ^d   Bian, Jin Song ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b Jiangxi Province People's Hospital   (China)

^c UNIVERSITY OF EXETER   (United Kingdom)

^d UNIVERSITY OF EXETER MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; CYCLIC AMP; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; HYDROGEN SULFIDE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MORPHINE; NALOXONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOWN REGULATION; ENZYME ACTIVATION; GENE OVEREXPRESSION; HIPPOCAMPUS; HUMAN; HUMAN CELL; MALE; MORPHINE ADDICTION; MOUSE; NONHUMAN; OPIATE ADDICTION; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; UPREGULATION;

ADENYLATE CYCLASE; ANALGESICS, OPIOID; ANIMALS; BEHAVIOR, ANIMAL; CELL LINE; CORPUS STRIATUM; CYCLIC AMP; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; GENE EXPRESSION REGULATION; HUMANS; HYDROGEN SULFIDE; MALE; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MORPHINE; MORPHINE DEPENDENCE; NALOXONE; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 84892151443     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2012.5119     Document Type: Article

References (49)

1. Chakrabarti S, Rivera M, Yan SZ, Tang WJ, and Gintzler AR. Chronic morphine augments G(beta)(gamma)/Gs(alpha) stimulation of adenylyl cyclase: relevance to opioid tolerance. Mol Pharmacol 54: 655-662, 1998.
2. Chakrabarti S, Wang L, Tang WJ, and Gintzler AR. Chronic morphine augments adenylyl cyclase phosphorylation: relevance to altered signaling during tolerance/dependence. Mol Pharmacol 54: 949-953, 1998.
3. Chan JS, Chiu TT, and Wong YH. Activation of type II adenylyl cyclase by the cloned mu-opioid receptor: coupling to multiple G proteins. J Neurochem 65: 2682-2689, 1995.
4. Chao JR, Ni YG, Bolanos CA, Rahman Z, DiLeone RJ, and Nestler EJ. Characterization of the mouse adenylyl cyclase type VIII gene promoter: regulation by cAMP and CREB. Eur J Neurosci 16: 1284-1294, 2002.
5. Crain SM and Shen KF. Ultra-low concentrations of naloxone selectively antagonize excitatory effects of morphine on sensory neurons, thereby increasing its antinociceptive potency and attenuating tolerance/dependence during chronic cotreatment. Proc Natl Acad Sci U S A 92: 10540-10544, 1995.
6. Deisseroth K, Bito H, and Tsien RW. Signaling from synapse to nucleus: postsynaptic CREB phosphorylation during multiple forms of hippocampal synaptic plasticity. Neuron 16: 89-101, 1996.
7. Enokido Y, Suzuki E, Iwasawa K, Namekata K, Okazawa H, and Kimura H. Cystathionine beta-synthase, a key enzyme for homocysteine metabolism, is preferentially expressed in the radial glia/astrocyte lineage of developing mouse CNS. FASEB J 19: 1854-1856, 2005.
8. Feinstein PG, Schrader KA, Bakalyar HA, Tang WJ, Krupinski J, Gilman AG, and Reed RR. Molecular cloning and characterization of a Ca2 + /calmodulin-insensitive adenylyl cyclase from rat brain. Proc Natl Acad Sci U S A 88: 10173-10177, 1991.
9. Fox B, Schantz JT, Haigh R, Wood ME, Moore PK, Viner N, Spencer JP, Winyard PG, and Whiteman M. Inducible hydrogen sulfide synthesis in chondrocytes and mesenchymal progenitor cells: is H2S a novel cytoprotective mediator in the inflamed joint? J Cell Mol Med 16: 896-910, 2012.
10. Glatt CE and Snyder SH. Cloning and expression of an adenylyl cyclase localized to the corpus striatum. Nature 361: 536-538, 1993.
11. Grewal SS, York RD, and Stork PJ. Extracellular-signal-regulated kinase signalling in neurons. Curr Opin Neurobiol 9: 544-553, 1999.
12. Guitart X, Thompson MA, Mirante CK, Greenberg ME, and Nestler EJ. Regulation of cyclic AMP response elementbinding protein (CREB) phosphorylation by acute and chronic morphine in the rat locus coeruleus. J Neurochem 58: 1168-1171, 1992.
13. Han MH, Bolanos CA, Green TA, Olson VG, Neve RL, Liu RJ, Aghajanian GK, and Nestler EJ. Role of cAMP response element-binding protein in the rat locus ceruleus: regulation of neuronal activity and opiate withdrawal behaviors. J Neurosci 26: 4624-4629, 2006.
14. Hu LF, Lu M, Hon Wong PT, and Bian JS. Hydrogen sulfide: neurophysiology and neuropathology. Antioxid Redox Signal 15: 405-419, 2011.
15. Ichinohe A, Kanaumi T, Takashima S, Enokido Y, Nagai Y, and Kimura H. Cystathionine beta-synthase is enriched in the brains of Down?s patients. Biochem Biophys Res Commun 338: 1547-1550, 2005.
16. Johnson SM and Fleming WW. Mechanisms of cellular adaptive sensitivity changes: applications to opioid tolerance and dependence. Pharmacol Rev 41: 435-488, 1989.
17. Kest B, Palmese CA, Hopkins E, Adler M, Juni A, and Mogil JS. Naloxone-precipitated withdrawal jumping in 11 inbred mouse strains: evidence for common genetic mechanisms in acute and chronic morphine physical dependence. Neuroscience 115: 463-469, 2002.
18. Kim KS, Lee KW, Lee KW, Im JY, Yoo JY, Kim SW, Lee JK, Nestler EJ, and Han PL. Adenylyl cyclase type 5 (AC5) is an essential mediator of morphine action. Proc Natl Acad Sci U S A 103: 3908-3913, 2006.
19. Kimura H. Hydrogen sulfide induces cyclic AMP and modulates the NMDA receptor. Biochem Biophys Res Commun 267: 129-133, 2000.
20. Kolachala V, Asamoah V, Wang L, Srinivasan S, Merlin D, and Sitaraman SV. Interferon-gamma down-regulates adenosine 2b receptor-mediated signaling and short circuit current in the intestinal epithelia by inhibiting the expression of adenylate cyclase. J Biol Chem 280: 4048-4057, 2005.
21. Lane-Ladd SB, Pineda J, Boundy VA, Pfeuffer T, Krupinski J, Aghajanian GK, and Nestler EJ. CREB (cAMP response element-binding protein) in the locus coeruleus: biochemical, physiological, and behavioral evidence for a role in opiate dependence. J Neurosci 17: 7890-7901, 1997.
22. Lee ZW, Zhou J, Chen CS, Zhao Y, Tan CH, Li L, Moore PK, and Deng LW. The slow-releasing hydrogen sulfide donor, GYY4137, exhibits novel anti-cancer effects in vitro and in vivo. PLoS One 6: e21077, 2011.
23. Li L, Whiteman M, Guan YY, Neo KL, Cheng Y, Lee SW, Zhao Y, Baskar R, Tan CH, and Moore PK. Characterization of a novel, water-soluble hydrogen sulfide-releasing molecule (GYY4137): new insights into the biology of hydrogen sulfide. Circulation 117: 2351-2360, 2008.
24. Li T, Hou Y, Cao W, Yan CX, Chen T, and Li SB. Naloxoneprecipitated withdrawal enhances ERK phosphorylation in prefrontal association cortex and accumbens nucleus of morphine-dependent mice. Neurosci Lett 468: 348-352, 2010.
25. Lim JJ, Liu YH, Khin ES, and Bian JS. Vasoconstrictive effect of hydrogen sulfide involves downregulation of cAMP in vascular smooth muscle cells. Am J Physiol Cell Physiol 295: C1261-C1270, 2008.
26. Liu JG and Anand KJ. Protein kinases modulate the cellular adaptations associated with opioid tolerance and dependence. Brain Res Brain Res Rev 38: 1-19, 2001.
27. Lu M, Liu YH, Goh HS, Wang JJ, Yong QC, Wang R, and Bian JS. Hydrogen sulfide inhibits plasma renin activity. J Am Soc Nephrol 21: 993-1002, 2010.
28. Maldonado R and Koob GF. Destruction of the locus coeruleus decreases physical signs of opiate withdrawal. Brain Res 605: 128-138, 1993.
29. Matsuoka I, Maldonado R, Defer N, Noel F, Hanoune J, and Roques BP. Chronic morphine administration causes regionspecific increase of brain type VIII adenylyl cyclase mRNA. Eur J Pharmacol 268: 215-221, 1994.
30. Nestler EJ and Aghajanian GK. Molecular and cellular basis of addiction. Science 278: 58-63, 1997.
31. Nestler EJ and Tallman JF. Chronic morphine treatment increases cyclic AMP-dependent protein kinase activity in the rat locus coeruleus. Mol Pharmacol 33: 127-132, 1988.
32. Njie-Mbye YF, Kulkarni M, Opere CA, and Ohia SE. Mechanism of action of hydrogen sulfide on cyclic AMP formation in rat retinal pigment epithelial cells. Exp Eye Res 98: 16-22, 2012.
33. Ortiz J, Harris HW, Guitart X, Terwilliger RZ, Haycock JW, and Nestler EJ. Extracellular signal-regulated protein kinases (ERKs) and ERK kinase (MEK) in brain: regional distribution and regulation by chronic morphine. J Neurosci 15: 1285-1297, 1995.
34. Patel TB, Du Z, Pierre S, Cartin L, and Scholich K. Molecular biological approaches to unravel adenylyl cyclase signaling and function. Gene 269: 13-25, 2001.
35. Pierre S, Eschenhagen T, Geisslinger G, and Scholich K. Capturing adenylyl cyclases as potential drug targets. Nat Rev Drug Discov 8: 321-335, 2009.
36. Punch LJ, Self DW, Nestler EJ, and Taylor JR. Opposite modulation of opiate withdrawal behaviors on microinfusion of a protein kinase A inhibitor versus activator into the locus coeruleus or periaqueductal gray. J Neurosci 17: 8520-8527, 1997.
37. Schulz S and Hollt V. Opioid withdrawal activates MAP kinase in locus coeruleus neurons in morphine-dependent rats in vivo. Eur J Neurosci 10: 1196-1201, 1998.
38. Sharma SK, Klee WA, and Nirenberg M. Opiate-dependent modulation of adenylate cyclase. Proc Natl Acad Sci U S A 74: 3365-3369, 1977.
39. Shaw-Lutchman TZ, Barrot M, Wallace T, Gilden L, Zachariou V, Impey S, Duman RS, Storm D, and Nestler EJ. Regional and cellular mapping of cAMP response elementmediated transcription during naltrexone-precipitated morphine withdrawal. J Neurosci 22: 3663-3672, 2002.
40. Shijun H, Liping Z, Yongqiang Q, Zhen L, Yonghe Z, and Lihua L. Morphine-induced changes of adenylate and guanylate cyclase in locus ceruleus, periaqueductal gray, and substantia nigra in rats. Am J Drug Alcohol Abuse 35: 133-137, 2009.
41. Strait KA, Stricklett PK, Chapman M, and Kohan DE. Characterization of vasopressin-responsive collecting duct adenylyl cyclases in the mouse. Am J Physiol Renal Physiol 298: F859-F867, 2010.
42. Tempel A and Zukin RS. Neuroanatomical patterns of the mu, delta, and kappa opioid receptors of rat brain as determined by quantitative in vitro autoradiography. Proc Natl Acad Sci U S A 84: 4308-4312, 1987.
43. Terwilliger RZ, Beitner-Johnson D, Sevarino KA, Crain SM, and Nestler EJ. A general role for adaptations in G-proteins and the cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function. Brain Res 548: 100-110, 1991.
44. Tiong CX, Lu M, and Bian JS. Protective effect of hydrogen sulphide against 6-OHDA-induced cell injury in SH-SY5Y cells involves PKC/PI3K/Akt pathway. Br J Pharmacol 161: 467-480, 2010.
45. Williams JT, Christie MJ, and Manzoni O. Cellular and synaptic adaptations mediating opioid dependence. Physiol Rev 81: 299-343, 2001.
46. Yang HY and Pu XP. Chronic morphine administration induces over-expression of aldolase C with reduction of CREB phosphorylation in the mouse hippocampus. Eur J Pharmacol 609: 51-57, 2009.
47. Yong QC, Pan TT, Hu LF, and Bian JS. Negative regulation of beta-Adrenergic function by hydrogen sulphide in the rat hearts. J Mol Cell Cardiol 44: 701-710, 2008.
48. Yu VC, Eiger S, Duan DS, Lameh J, and Sadee W. Regulation of cyclic AMP by the mu-opioid receptor in human neuroblastoma SH-SY5Y cells. J Neurochem 55: 1390-1396, 1990.
49. Zachariou V, Liu R, LaPlant Q, Xiao G, Renthal W, Chan GC, Storm DR, Aghajanian G, and Nestler EJ. Distinct roles of adenylyl cyclases 1 and 8 in opiate dependence: behavioral, electrophysiological, and molecular studies. Biol Psychiatry 63: 1013-1021, 2008.